Concepedia

Matthias Hipp

MH

Statistics

Publications

18

Citations

1.4K

H-Index

14

Active since

2006

Affiliations

University of Regensburg(Current)

Klinikum St. Marien Amberg

Martin Luther University Halle-Wittenberg

University Hospital Heidelberg

University of Würzburg

Matthias Hipp is an author at University of Regensburg specializing in oncology, medicine, and radiation oncology.

Publications per year

2006–2020

18

Publications

18

Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial

Ralf‐Dieter Hofheinz, Frederik Wenz, Stefan Post et al. · The Lancet Oncology · 2012 · 507 citations

, , +12

Multicenter Phase II Trial of Chemoradiation With Oxaliplatin for Rectal Cancer

Claus Rödel, Torsten Liersch, Robert Michael Hermann et al. · Journal of Clinical Oncology · 2006 · 229 citations

, , +17

Phase I-II Trial of Cetuximab, Capecitabine, Oxaliplatin, and Radiotherapy as Preoperative Treatment in Rectal Cancer

Claus Rödel, Dirk Arnold, Matthias Hipp et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 143 citations

, , +16

Fistula-associated anal adenocarcinoma in Crohnʼs disease

Igors Iesalnieks, Wolfgang B. Gaertner, Heidi Gla et al. · Inflammatory Bowel Diseases · 2010 · 105 citations · Full text

, , +16

Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases

Diana Steinmann, Yvonne Paelecke–Habermann, Hans Geinitz et al. · BMC Cancer · 2012 · 98 citations · Full text

, , +15

1–5 of 18